![](https://porib.com/wp-content/uploads/2021/07/journal_viral_hepatitis.jpg)
Vargas-Accarino E, Martínez-Campreciós J, Domínguez-Hernández R, Rando-Segura A, Riveiro-Barciela M, Rodríguez-Frías F, Barreira A, Palom A, Casado MA, Esteban R, Buti M
Cost-effectiveness análisis of an active search to retrieve lost-to follow-up HCV patients (RELINK-C strategy): health, economic value and COVID-19 impact
J Viral Hepat. DOI: 10.1111/jvh.13686
![](https://porib.com/wp-content/uploads/2021/07/gastroenterologia_y_hepatologia.jpg)
Crespo J, Cabezas J, Aguilera A, Berenguer M, Buti M, Forns X, García F, García-Samaniego J, Hernández-Guerra M, Jorquera F, V Lazarus J, Lens S, Martró E, Pineda JA, Prieto M, Rodríguez-Frías F, Rodríguez M, Serra MA, Turnes J, Domínguez-Hernández R, Casado MA, Calleja JL
Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica
Gastroenterología y Hepatología. Doi.org/10.1016/j.gastrohep.2022.09.009
![](https://porib.com/wp-content/uploads/2021/07/adicciones.jpg)
Colom J, Torrens M, Rodríguez-Cejas A, Aguilar I, Álvarez-Crespo R, Armenteros L, Ayala V, Cantero H, Casado MA, Crespo j, Estévez J, García-Samaniego J, Hernández-GuerraM, Mu C, Pérez-Bech E, Ricote M, Pineda JA
Programa de certificación de Centros de Adicciones para la eliminación del virus de la hepatitis C en España. Proyecto HepCelentes Certification program of Addiction Centres for hepatitis C virus elimination in Spain. HepCelentes Project
Adicciones (In Press)
MÁS INFORMACIÓN
![](https://porib.com/wp-content/uploads/2021/07/plos_one-1.jpg)
Esteban R, Domínguez-Hernández R, Martín-Escudero V, Casado MA
Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain
Plos One. Doi.org/10.1371/journal.pone.0278544
![](https://porib.com/wp-content/uploads/2021/07/Revista-E-Enfermedades-Digestivas.jpg)
Crespo J, Cabezas J, Mateo Soler M, de la Cuadra-Grande A, Casado MA, Lazarus JV, Calleja JL
Current state of telemedicine in the field of Hepatology in Spain: challenges, threats and next steps to follow for an intelligent digital transformation
Rev Esp Enferm Dig 2023; 115(5):248-258
Buti M, Calleja JL, Rodríguez MÁ, Cantero H, de las Heras A, Domínguez-Hernández R, Casado MÁ
Bulevirtide avoids future clinical events and related costs compared to pegylated-interferon alpha in chronic hepatitis D in Spain
International Liver Congress (EASL). London. 22-26 jun 2022
Esteban R, Domínguez-Hernández R, Cantero H, Casado MA
Evaluation of the clinical and economic value of sofosbuvir / velpatasvir (SOF / VEL) in patients with chronic hepatitis C in Spain during the last 5 years
International Liver Congress (EASL). London. 22-26 jun 2022
![](https://porib.com/wp-content/uploads/2021/07/journal_viral_hepatitis.jpg)
Hernández R, Rando-Segura A, Riveiro-Barciela M, Rodríguez-Frías F, Barreira A, Palom A, Casado MA, Esteban R, Buti M
Active search to retrieve lost-to follow-up HCV patients (RELINK-C strategy): health, economic value and COVID-19 impact
J Viral Hepat. DOI: 10.1111/jvh.13686
Buti M, Calleja JL, Rodríguez MÁ, Cantero H, de las Heras A, Domínguez-Hernández R, Casado MÁ